Conditions: Actinic Keratosis
Keywords: Peplin Actinic keratosis PEP005
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 269
Healthy volunteers: no

Brief summary:
This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.

Detailed description:

Arms:
arm 1: PEP005 gel, 0.015% applied once daily for three consecutive days arm 2: Vehicle gel applied once daily for three consecutive days

Interventions: intervention 1: PEP005 Gel intervention 2: Vehicle gel
Intervention descriptions: intervention 1: 0.015%, three day treatment intervention 2: Vehicle gel, three day treatment

Protocol document: